Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Summary

Here, we present a protocol for the determination of intracellular signaling events induced in viable cells by physical interaction with adjacent dead or dying cells. The protocol focuses on signaling events induced by receptor-mediated recognition of the dead cells, as opposed to their phagocytic uptake or release of soluble mediators.

Abstract

Cells dying by apoptosis, also referred to as regulated cell death, acquire multiple new activities that enable them to influence the function of adjacent live cells. Vital activities, such as survival, proliferation, growth, and differentiation, are among the many cellular functions modulated by apoptotic cells. The ability to recognize and respond to apoptotic cells appears to be a universal feature of all cells, regardless of lineage or organ of origination. However, the diversity and complexity of the response to apoptotic cells mandates that great care be taken in dissecting the signaling events and pathways responsible for any particular outcome. In particular, one must distinguish among the multiple mechanisms by which apoptotic cells can influence intracellular signaling pathways within viable responder cells, including: receptor-mediated recognition of the apoptotic cell, release of soluble mediators by the apoptotic cell, and/or engagement of the phagocytic machinery. Here, we provide a protocol for identifying intracellular signaling events that are induced in viable responder cells following their exposure to apoptotic cells. A major advantage of the protocol lies in the attention it pays to dissection of the mechanism by which apoptotic cells modulate signaling events within responding cells. While the protocol is specific for a conditionally immortalized mouse kidney proximal tubular cell line (BU.MPT cells), it is easily adapted to cell lines that are non-epithelial in origin and/or derived from organs other than the kidney. The use of dead cells as a stimulus introduces several unique factors that can hinder the detection of intracellular signaling events. These problems, as well as strategies to minimize or circumvent them, are discussed within the protocol. Application of this protocol should aid our expanding knowledge of the broad influence that dead or dying cells exert on their live neighbors, both in health and in disease.

Introduction

Apoptosis, or regulated cell death¹, contributes in an essential manner to the maintenance and development of tissues. Viewed most simply, apoptosis permits aged, damaged, or excess cells to be eliminated without harm to surrounding tissues^2,3. The contribution of apoptosis to tissue homeostasis, however, is considerably more dynamic and varied. Cells dying by apoptosis acquire multiple new activities, both secreted and cell-associated, which enable them to influence the function of adjacent live cells^4-10. Earlier studies focused on the ability of apoptotic cells to suppress inflammation^11-16, but apoptotic cells also modulate a broad range of cellular functions, including such vital activities as survival^4,9,10, proliferation^4,9,10, differentiation¹⁷, migration¹⁸, and growth¹⁹. Moreover, these effects are not restricted to professional phagocytes, like macrophages, but extend to virtually all cell types and lineages, including traditionally non-phagocytic cells, such as epithelial and endothelial cells^7,9,10,18-21.

The specific response of adjacent live cells following exposure to apoptotic cells depends on multiple factors that relate to both the viable responding cells and the apoptotic cells themselves. For example, although exposure to apoptotic cells inhibits the proliferation of both murine macrophages and kidney proximal tubular epithelial cells (PTECs), these two cell types differ dramatically in their survival response to apoptotic cells^4,6,9,10. Apoptotic cells promote the survival of macrophages, but induce the apoptotic death of PTECs^4,6,9,10. Notably, the response to apoptotic cells may differ even among responding cells of the same lineage, depending on the responding cell's organ of origin¹⁰ (e.g., kidney PTECs versus mammary epithelial cells) or state of activation²² (e.g., neutrophils). Conversely, apoptotic cells may evoke different responses in the very same cell depending on the nature of the apoptotic stimulus^10,23 or the stage of apoptosis^10,14.

Given the diverseness and complexity of the response to apoptotic cells, great care must be taken in dissecting the signaling events and pathways responsible for any particular outcome. First, responses requiring direct physical interaction between viable and apoptotic cells must be differentiated from those elicited by soluble mediators released or generated by the apoptotic cell^3,6-10. If physical interaction is required, then a further differentiation should be performed. Signaling events may depend on receptor-mediated recognition of the apoptotic cell, independent of subsequent engulfment, or on phagocytic uptake, independent of the specific receptor that binds the apoptotic cell^3-7,9,10,19. In the latter instance, the response is not specific to apoptotic cells, and can be triggered by any phagocytic material^4,6.

The importance of these distinctions can again be appreciated by contrasting the responses of macrophages and kidney PTECs. For both cell types, exposure to apoptotic cells alters the activity of the pro-survival kinase Akt. Modulation is dependent on physical interaction, since separation of responding and apoptotic cells by a 0.4 μm polycarbonate membrane abolishes the response^4,9,10,19. However, the response of PTECs is receptor-mediated and independent of phagocytosis, whereas the response of macrophages is driven by phagocytosis^4,9,10,19. This conclusion is reinforced by the fact that exposure to latex beads, a neutral phagocytic stimulus, has no effect on Akt activity in PTECs, but mimics the effect of apoptotic cells in macrophages^4,9.

Although less well studied, cells dying by necrosis, or accidental cell death¹, also modulate the function of nearby viable cells^3-10,19. Like apoptotic cells, necrotic cells exert their effects through a variety of mechanisms, particularly the leakage of intracellular contents through their ruptured cell membrane^3,5,6,9,24. Many cells, including PTECs and macrophages, possess distinct non-competing receptors for cells dying by necrosis^5,9. Engagement of these receptors induces signaling events that are often opposite to those induced by engagement of the receptors for apoptotic cells^4-10,19. For example, in PTECs, necrotic cells increase phosphorylation of Akt, whereas apoptotic cells decrease phosphorylation^9,10,19.

Here, we describe a protocol for identifying intracellular signaling events induced in viable kidney PTECs through receptor-mediated recognition of adjacent apoptotic PTECs^9,10,19. While the protocol is specific for a conditionally immortalized PTEC cell line known as BU.MPT cells^{9,10,19,25,26}, it is easily adapted to cell lines that are non-epithelial in origin and/or derived from organs other than the kidney. Importantly, the use of apoptotic cells as a cell stimulus poses certain inherent experimental difficulties not present with soluble ligands. The most important of these is that apoptotic cells must be added as a suspension rather than as a solution. These difficulties, as well as strategies to minimize or circumvent them, are discussed within the protocol. Nearly all of the techniques described in the protocol are straightforward and standard to cell culture. The advantage of this protocol lies in its attention to the multiple mechanisms by which apoptotic cells modulate signal transduction within responding cells. These mechanisms include the binding via surface determinants or bridging molecules to specific receptors on the responding cell, the release of soluble mediators, and/or the engagement of the phagocytic machinery. Necrotic cells are included in all experiments to ensure that results are specific to the mode of cell death, and not a generalized response to dead cells. A careful approach, as recommended in this protocol, is critical to our understanding of the ever expanding influence that dying cells exert on their live neighbors, in both health and disease.

Protocol

1. Preparations

Note: In this protocol, two or more cell lines, or primary cell cultures, are independently prepared under specific conditions. These preparations include apoptotic cells (Protocol 1), necrotic cells (Protocol 2), and healthy responder cells (Protocol 3). After independent preparation, apoptotic or necrotic cells are added to responder cells and the resulting signal transduction is monitored (Protocols 4, 5, and 6).

1. Prepare culture media and reagents
   1. Prepare 500 mL of culture medium A (for use when growing cells under permissive conditions, see section 1.2) by combining the following: 1x Dulbecco's Modified Eagle's Medium (DMEM) containing 4.5 g/L glucose, 584 mg/L ʟ-glutamine, 110 mg/L sodium pyruvate, 100 units/mL penicillin-streptomycin, 10% (v/v) fetal bovine serum (FBS), and 10 units/mL of interferon-γ (IFN-γ).
   2. Prepare 500 mL of culture medium B (for use when serum-starving cells under non-permissive conditions, see section 1.2) by omitting FBS and IFN-γ from the recipe of culture medium A. To grow cells under non-permissive conditions (prior to serum-starvation), add 10% v/v FBS to culture medium B.
   3. Prepare 0.4% (v/v) paraformaldehyde, pH 7.2, in 1x Dulbecco's phosphate buffered saline (DPBS) from 4% stock paraformaldehyde for fixation of dead cells.
      Note: Paraformaldehyde is toxic, and appropriate caution should be exercised in its use.
2. Culture BU.MPT cells
   1. Thaw from liquid nitrogen one vial of BU.MPT cells.
      Note: BU.MPT is a mouse kidney proximal tubular epithelial cell (PTEC) line derived from a transgenic mouse bearing a temperature-sensitive (ts) mutation (tsA58) of the SV40 large tumor antigen (TAg) under the control of the mouse major histocompatibility complex (MHC) H-2K^b class I promoter^25,26.
   2. Plate cells on sterile polystyrene vacuum-gas plasma treated tissue culture dishes (~ 5 x 10⁶ cells per 100 mm diameter dish).
   3. Grow cells under permissive conditions in a humidified 5% (v/v) CO₂ atmosphere.
      Note: Permissive conditions, which are defined as culture at 33 - 37 ºC in the presence of IFN-γ, enable stable expression of the tsA58-mutated TAg transgene. Unlike primary cultures of mouse kidney PTEC, which do not survive more than a single passage or two, BU.MPT cultured under permissive conditions can be passaged indefinitely.
      1. Passage cells at least three times after thawing before using them in an experiment.
         1. To passage cells, add 1 mL of 0.05% trypsin per 100 mm dish, and incubate in a humidified 5% (v/v) CO₂ atmosphere at 37 ºC for 5 min. Neutralize the trypsin by adding 10 mL of medium A. Aspirate the detached cells, and split 1:3 to 1:5 into new 100 mm sterile polystyrene vacuum-gas plasma treated tissue culture dishes. Add medium A to bring the volume up to a total of 10 mL per 100 mm dish.
   4. In preparation for experimental use as responding cells, grow cells to confluence in a humidified 5% (v/v) CO₂ atmosphere under non-permissive conditions (i.e. at 39 ºC in the absence of IFN-γ [medium B containing 10% v/v FBS]).
      Note: Under non-permissive conditions, expression of the tsA58-mutated TAg transgene is inhibited by >95%, and BU.MPT cells behave like primary cultures of mouse kidney PTEC.

2. Preparation of Apoptotic BU.MPT Cells (Protocol 1)

Note: This protocol is specific for BU.MPT cells as the source of apoptotic cells, and staurosporine as the method of apoptosis induction. Alternatively, another cell line, or primary cell culture, may be used as a source of apoptotic cells, with apoptosis induced by standardized protocols for that particular cell type and method of apoptosis induction.

1. After passage onto 100 mm diameter sterile polystyrene vacuum-gas plasma treated tissue culture dishes, grow BU.MPT cells to confluence in a humidified 5% (v/v) CO₂ atmosphere under permissive conditions (i.e. at 37 ºC in culture medium A at 10 mL per 100 mm dish), as described in section 1.2.3.
2. Rinse the adherent cell monolayer three times with culture medium B, using 10 mL per rinse.
3. Induce apoptosis by incubating the cells in culture medium B containing staurosporine, a nonselective protein kinase inhibitor, at 1 µg/mL for 3 h in a humidified 5% (v/v) CO₂ atmosphere at 37 ºC.
4. Aspirate the staurosporine-containing medium containing "floating" apoptotic cells that have detached from the monolayer. Centrifuge this medium for 10 min at 500 x g, discard the supernatant, wash the pellet three times with culture medium B, and add the pellet back to cells collected in the next step, 2.5.
5. Detach the remaining adherent cells from steps 2.3 and 2.4 by addition of 5 mM (ethylenediaminetetraacetic acid) EDTA in 1x Ca²⁺- and Mg²⁺-free DPBS at 1 mL per dish for 5 min. Aspirate the EDTA-containing medium containing detached apoptotic cells, and pool the detached cells with the "floating" apoptotic cells from step 2.4 in a sterile 15 mL polystyrene centrifuge tube.
6. Wash the apoptotic cells three times by centrifugation for 10 min at 500 x g and resuspension in 10 mL of 1x Ca⁺²- and Mg⁺²-free DPBS per wash.
7. After the last wash, suspend the apoptotic cells in fresh culture medium B at ~ 5 x 10⁶ cells per mL before use to stimulate responder cells. Alternatively, fix washed apoptotic cells in 0.4% (v/v) paraformaldehyde in 1x DPBS for 30 min, and then wash three times with culture medium B, before suspension in culture medium B.
8. As appropriate, confirm induction of apoptosis by flow cytometry using a separate preparation of apoptotic cells (or by reserving some cells for this purpose), as previously described^6,9,10,15.
   Note: Early apoptotic cells have intact cell membranes, and appear as propidium iodide (PI)-negative and annexin V-positive cells of decreased cell size (relative to viable cells). Late apoptotic cells have non-intact cell membranes, and appear as PI-positive and annexin V-positive cells of decreased cell size. Using the current protocol, typical preparations contain ~ 85% early apoptotic and ~ 15% late apoptotic cells.
9. Add apoptotic cells to BU.MPT responder cells (Protocol 3) at an apoptotic-to-responder cell ratio of 1:1, either directly or after fixation of apoptotic cells for 30 min with 0.4% (v/v) paraformaldehyde in 1x DPBS.
   Note: Apoptotic cell fixation prior to stimulation of responders should not affect results, unless the observed signaling events are due to release of a soluble mediator (Table 1).

3. Preparation of Necrotic BU.MPT Cells (Protocol 2)

Note: This protocol is specific for BU.MPT cells as the source of necrotic cells, and heating as the method of necrosis induction. Alternatively, another cell line, or primary cell culture, may be used as a source of necrotic cells, with necrosis induced by standardized protocols for that particular cell type and method of necrosis induction.

1. After passage onto 100 mm diameter sterile polystyrene vacuum-gas plasma treated tissue culture dishes, grow BU.MPT cells to confluence in a humidified 5% (v/v) CO₂ atmosphere under permissive conditions (i.e. at 37 ºC in culture medium A at 10 mL per dish), as described in section 1.2.3.
2. Rinse the adherent cell monolayer three times with culture medium B, using 10 mL per rinse.
3. Detach the cells by addition of 5 mM EDTA in 1x Ca⁺²- and Mg⁺²-free DPBS at 1 mL per dish for 5 min. Aspirate the EDTA-containing medium containing detached cells, and add the cell suspension to a sterile 15 mL polystyrene centrifuge tube.
4. Wash the cells three times by centrifugation for 10 min at 500 x g and resuspension in 10 mL of Ca⁺²- and Mg⁺²-free DPBS per wash.
5. After the last wash, suspend the cells in fresh culture medium B at ~ 5 x 10⁶ cells per mL.
6. Induce necrosis by heating cells to 70 ºC for 45 min in a water bath, gently vortexing the cell suspension every 10 min.
7. Incubate cells for 2 h in a humidified 5% (v/v) CO₂ atmosphere at 37 °C. Gently vortex the cell suspension every 15 min.
8. As appropriate, confirm induction of necrosis by flow cytometry using a separate preparation of necrotic cells (or by reserving some cells for this purpose), as previously described^6,9,10,15.
   Note: Necrotic cells have ruptured cell membranes, and appear as PI-positive cells of increased cell size (relative to viable cells). Using the current protocol, typical preparations contain ≥ 95% necrotic cells. Alternatively, induction of necrosis and loss of membrane integrity may be confirmed by Trypan blue staining.

4. Preparation of BU.MPT Responder Cells (Protocol 3)

Note: This protocol is specific for BU.MPT cells as the source of responder cells. Alternatively, another cell line, or primary cell culture, may be used as responder cells. Prior to experimental use, quiescence may be induced overnight by standardized protocols within the laboratory.

1. Grow BU.MPT cells in sterile 100 mm tissue culture dishes under permissive conditions in culture medium A at 10 mL per dish until they achieve ~ 85% confluence.
2. Aspirate culture medium A, and rinse the cells three times with culture medium B at 10 mL per rinse. Serum-starve the cells overnight for 18 to 24 h in a humidified 5% (v/v) CO₂ atmosphere under non-permissive conditions (i.e. at 39 ºC in culture medium B at 10 mL per dish), as described in section 1.2.4, in order to induce quiescence. Alternatively, grow cells in culture medium B plus 10% (v/v) FBS at 39 ºC for one day before serum starving cells overnight in culture medium B without FBS.
3. Label a separate tissue culture dish of confluent BU.MPT cells for each experimental condition.
4. Include the following six conditions: stimulation of viable BU.MPT responders with either vehicle or epidermal growth factor (EGF) for 15 min, following their exposure for 30 min to either no cells, apoptotic cells, or necrotic cells.
   Note: Exposure to dead cells may either stimulate or inhibit the level of activity of a given signaling molecule. Stimulation is best detected above a low baseline (e.g., absence of EGF), whereas inhibition is best detected from a high baseline (e.g., presence of EGF). Since the effect of stimulation with dead cells is a priori unknown, it is recommended to perform all studies in both the absence and the presence of EGF.

5. Stimulation of Responder Cells with Apoptotic and Necrotic Cells (Protocol 4)

1. Aspirate culture medium B from pre-labeled dishes of quiescent (serum-starved) BU.MPT responder cells (Protocol 3).
   Note: After overnight culture under non-permissive conditions, BU.MPT cells should behave like primary cultures of mouse kidney PTEC.
2. Per 100 mm dish, add 2 mL of one of the following: culture medium B (no cells); apoptotic cell suspension at ~ 5 x 10⁶ cells per mL in culture medium B (Protocol 1); or necrotic cell suspension at ~ 5 x 10⁶ cells per mL in culture medium B (Protocol 2).
   1. Distribute the 2 mL suspension of dead cells evenly over the 100 mm dish, and keep the time for them to settle to a minimum. To achieve this, distribute the dead cell suspension drop by drop with a wide tip pipette over the entire surface of the responder cell dishes. Use a volume of 2 mL as a compromise between minimizing the settling time and avoiding the clumping of dead cells.
      Note: The use of a suspension of dead cells as a stimulus entails a number of special considerations, which are described below in greater detail (Table 2 and Discussion).
   2. Achieve a dead-to-responder cell ratio of ~ 1:1 by adding 2 mL of dead cells at ~ 5 x 10⁶ cells per mL to a confluent 100 mm dish, which contains ~ 10 x 10⁶ cells. Alternatively, in order to establish the dose-dependency of any observed signaling events, vary the ratio of dead to responder cells continuously by progressive dilution in culture medium B of the dead cell suspensions prepared in Protocols 1 and 2.
3. Gently swirl the dishes, then incubate at 37 ºC in a humidified 5% (v/v) CO₂ atmosphere.
4. After 30 min, stimulate the responder cells with either vehicle or 50 nM EGF, according to the pre-labeling of the culture dish.
5. Incubate for 15 min at 37 °C in a humidified 5% (v/v) CO₂ atmosphere.
6. Wash away the dead cells by adding 5 mL of ice-cold 1x DPBS, swirling the dish, and aspirating the wash fluid. Repeat three times.
7. Immediately place the responder cell dishes on ice for further processing.
8. Prepare cell lysates
   1. Prepare cell lysis buffer containing the following: 1× Tris buffered saline (TBS), 10 mM sodium pyrophosphate, 0.5% w/v deoxycholate, 0.1% w/v SDS, 10% glycerol, and 25 mM sodium fluoride.
      1. Immediately prior to cell lysis, add the following in the exact order given at the indicated concentrations: mini EDTA-free protease inhibitor cocktail (1 tablet per 10 mL of lysis buffer), 10% (v/v) Triton X-100, 1 mM dithiothreitol (DTT), 1 mM phenylmethanesulfonyl fluoride (PMSF), and 10 mM sodium orthovanadate.
   2. Add 700 µL of ice-cold cell lysis buffer per 100 mm dish of freshly stimulated responder cells on ice from step 5.7. Scrape cells with a cell scraper, and transfer the lysate to pre-chilled 1.5 mL microtubes. Maintain the tubes on ice for 15 min.
   3. Sonicate lysates on ice with 10 pulses of 20 Hz, less than one second each in duration. Avoid the creation of foam at the gas/liquid interface, as this can overheat the samples. Fully immerse the sonicator probe into the microtubes containing lysates before switching the sonicator on, and switch the sonicator off before removing the probe from the lysates.
   4. Centrifuge at 20,000 x g for 10 min at 4 °C, transfer the supernatants into fresh pre-chilled microtubes, and store at -70 ºC.
   5. Perform gel electrophoresis and immunoblotting on supernatants of lysates, as previously described^6,9,10,15.

6. Preventing Direct Physical Contact between Targets and Responders Using a Semipermeable Polycarbonate Membrane (Protocol 5)

1. Prepare BU.MPT responder cells according to Protocol 3, with one exception; grow cells in sterile polystyrene tissue culture treated 12-well clusters.
2. In selected wells, place a permeable support system containing a 0.4 µm polycarbonate membrane to prevent physical interaction between dead and responder cells. Include control wells without a membrane in the same experiment.
3. Aspirate culture medium B from experimental wells of serum-starved BU.MPT responder cells.
4. Follow Protocol 4 for stimulation of responder cells with apoptotic or necrotic cells, with the following modifications:
   1. Per well of the 12-well cluster, add 0.1 mL of one of the following: culture medium B (no cells); apoptotic cell suspension at ~5 x 10⁶ cells per mL in culture medium B (Protocol 1); or necrotic cell suspension at ~5 x 10⁶ cells per mL in culture medium B (Protocol 2).
      Note: As a confluent well of a 12-well cluster contains ~ 0.5 x 10⁶ cells, the addition of 0.1 mL of dead cells at ~ 5 x 10⁶ cells per mL yields a dead-to-responder cell ratio of ~ 1:1.
   2. To wells containing the permeable support system, add the dead cells on top of the 0.4 µm polycarbonate membrane within the permeable support system, so there is no direct physical interaction between dead and responder cells.

7. Inhibition of Phagocytosis with Cytochalasin D (Protocol 6)

1. Prepare BU.MPT responder cells according to Protocol 3.
2. Prepare the cytoskeletal inhibitor cytochalasin D in dimethyl sulfoxide (DMSO) at 4 mg/mL (1,000×). Add to pre-labeled dishes of BU.MPT responder cells either 10 μL of vehicle (DMSO) or 10 μL of cytochalasin D to achieve a final concentration of 4 μg/mL in 10 mL of culture medium B.
   Note: At this concentration of cytochalasin D, phagocytosis by BU.MPT cells and a macrophage cell line was inhibited by ≥90%^9,10.
3. Incubate for 2 h at 37 ºC in a humidified 5% (v/v) CO₂ atmosphere.
4. Follow Protocol 4 for stimulation of responder cells with apoptotic or necrotic cells.
5. As appropriate, confirm inhibition of phagocytosis of dead cells by flow cytometry using a separate preparation of dead and responder cells (or cells reserved for this purpose), as previously described^9,10.

Results

In Figure 1, we provide a schematic depicting the timing and critical steps involved in the preparation of apoptotic cells (Protocol 1) and necrotic cells (Protocol 2) and the stimulation of responder cells with suspensions of apoptotic and necrotic cells (Protocol 4).

In Figure 2, we provide representative results showing the effect of apoptotic cells on phosphorylation of the two isoforms of t...

Discussion

We provide here a protocol for characterizing the intracellular signaling events induced in viable cells following their exposure to cells undergoing apoptosis, or other forms of cell death. The protocol emphasizes the multiple mechanisms by which exposure to apoptotic cells can modulate intracellular signaling pathways within viable responder cells. These mechanisms include: the interaction (via bridging molecules or surface determinants on the dead cell or its shed vesicles and microvesicles, often termed apoptotic bod...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Cell culture materials
DMEM, 1x with [4.5 g/L] glucose, ʟ-glutamine & sodium-pyruvate	Mediatech (Manassas, VA)	10-013-CV
HyClone Fetal Clone II, fetal bovine serum	GE Healthcare (Logan, UT)	SH30066.03	add 10% (v/v)  to the culture medium A
Penicillin-Streptomycin-Glutamine, 100x	Life Technologies (Grand Island, NY)	10378-016	add 100 units/mL to the culture media A and B
γ-Interferon, mouse recombinant, from Escherichia coli	Calbiochem, Millipore (Billerica, MA)	407303	add 10 units/mL to the culture medium A
Falcon polystyrene tissue-culture treated dishes, non-pyrogenic	Corning (Durham, NC)	353003	sterile, 100 mm diameter
Falcon polystyrene centrifuge tubes, conical bottom	Corning (Durham, NC)	352095	sterile, 15 mL
Trypsin-EDTA, 0.05%, Gibco	Fisher (Waltham, MA)	25300062	sterile, 100 mL
Name	Company	Catalog	Comments
Chemicals and inhibitors
Staurosporine, from Streptomyces sp.	Sigma (St. Louis, MO)	S4400	use at [1 μg/mL] for 3 h to induce apoptosis
Epidermal growth factor (EGF), [1 mg/mL]	Millipore (Billerica, MA)	EA140	use at 50 nM to stimulate responder cells
UltraPure, 0.5 M EDTA, pH 8.0	Life Technologies (Grand Island, NY)	15575-038	use 5 mM to detach adherent cells
Trypan blue solution, 0.4%	MP Biomedicals (Santa Ana, CA)	91691049	for dead cells staining
Paraformaldehyde Solution, 4% in DPBS	Affymetrix (Santa Clara, CA)	19943	use 0.4% (v/v) in 1x DPBS for cell fixation
Dulbecco's phosphate-buffered saline (DPBS), 1x, Gibco	Life Technologies (Grand Island, NY)	14040133	stock solution
Dulbecco's phosphate-buffered saline (DPBS), Ca2+- and Mg2+-free, 1x, Gibco	Life Technologies (Grand Island, NY)	14190367	stock solution
Cytochalasin D, 4 mM in dimethyl sulfoxide (DMSO), from Zygosporium mansonii	Sigma (St. Louis, MO)	C8273	use at [4 μg/mL] to inhibit phagocytosis
Dimethyl sulfoxide (DMSO)	Sigma (St. Louis, MO)	D2650	solvent for cytochalasin D
[header]
Cell lysis buffer ingredients
Tris-buffered saline (TBS), 10x, pH 7.4	BioRad (Hercules, CA)	1706435	for cell lysis buffer
Sodium pyrophosphate	Sigma-Aldrich (St. Louis, MO)	221368	10 mM for cell lysis buffer
Sodium deoxycholate	Sigma-Aldrich (St. Louis, MO)	D6750	0.5% w/v for cell lysis buffer
Sodium dodecyl sulfate (SDS)	Sigma-Aldrich (St. Louis, MO)	L3771	0.1% w/v for cell lysis buffer
Glycerol	Sigma-Aldrich (St. Louis, MO)	G5516	10% for cell lysis buffer
Sodium fluoride	Sigma-Aldrich (St. Louis, MO)	450022	25 mM for cell lysis buffer
Complete mini EDTA-free protease inhibitor cocktail tablet	Roche Diagnostics (Indianapolis, IN)	4693159001	for cell lysis buffer, 1 tablet per 10 mL of buffer
Triton X-100	Sigma-Aldrich (St. Louis, MO)	T8787	10% for cell lysis buffer
Dithiothreitol (DTT)	MP Biomedicals (Santa Ana, CA)	11DTT00005	1 mM for cell lysis buffer
Phenylmethanesulfonyl fluoride (PMSF)	MP Biomedicals (Santa Ana, CA)	4800263	1 mM for cell lysis buffer
Sodium orthovandate	MP Biomedicals (Santa Ana, CA)	2159664	10 mM for cell lysis buffer
Name	Company	Catalog	Comments
Equipment
Sorvall T6000B centrifuge	Du Pont (Wilmington, DE)	T6000B
Fisher Tissuemat, water bath	Fisher (Waltham, MA)
Sonic Dismembrator (sonicator), model 100	Fisher (Waltham, MA)
Miscellaneous
Cell counting chamber, Neubauer	Hawksley (Lancing, Sussex, UK)	AC2000
Annexin V-FITC Apoptosis Detection Kit II	Millipore (Billerica, MA)	CBA059	for PI and Annexin V staining to determine the stage of apoptosis
Eppendorf microcntrifuge tubes, 1.5 mL	Sigma-Aldrich (St. Louis, MO)	T9661
Transwell permeable support, 0.4 μm polycarbonate membrane	Corning (Corning, NY)	3413	sterile, polystyrene, tissue culture treated
Name	Company	Catalog	Comments
Antibodies
Phospho-glycogen synthase kinase-3α/β (GSK-3α/β) (Ser21/9), polyclonal antibody	Cell Signaling Technology	9331	rabbit polyclonal antibody
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) monoclonal antobody ( (14C10) )	Cell Signaling Technology	2118	rabbit monoclonal antibody